Sirtuins

Sirtuin inhibitors and activators target the seven mammalian sirtuins, a family of protein deacetylases. Yeast silent information regulator 2 (Sir2), the founding member, is a histone deacetylase that requires nicotinamide adenine dinucleotide (NAD+). Human sirtuins (SIRT1 to SIRT7) differ in location, with SIRT1 mainly nuclear, SIRT2 mainly cytoplasmic and SIRT3 to SIRT5 in mitochondria. Selisistat, also known as EX-527, inhibits SIRT1, and SirReal2 selectively inhibits SIRT2. SRT1720 HCl and SRT2104 are described as synthetic SIRT1 activators. Nicotinamide, a product of the sirtuin reaction, inhibits sirtuin activity, while nicotinamide riboside is a precursor of NAD+.

Items 101-125 of 151

  • Cannabisin F
    Cat. No.
    A56990

    Cannabisin F

    Cannabisin F is a modulator of SIRT1, derived from hempseed lignanamide. It exhibits significant anti-inflammatory and antioxidant properties, making it a valuable candidate for research focused on neurodegenerative diseases. Cannabisin F may influence critical pathways involving SIRT1, NF-κB, and Nrf2, contributing to its potential therapeutic applications.

    1 mg
    $385.00
    5 mg
    $985.00
    All 2 sizes
  • Z26395438
    Cat. No.
    A56991

    Z26395438

    Z26395438 is a potent inhibitor of Sirtuin-1, exhibiting an IC50 value of 1.6 μM. This compound is instrumental in research involving metabolic regulation, aging, and cellular stress responses. Its ability to modulate Sirtuin activity highlights its potential applications in studying various physiological and pathological processes.

    1 mg
    $25.00
    5 mg
    $60.00
    All 6 sizes
  • Sirtuin modulator 3
    Cat. No.
    A56992

    Sirtuin modulator 3

    Sirtuin modulator 3 is a N-phenyl benzamide derivative that functions as a sirtuin modulator. This compound has been shown to influence sirtuin activity, which is implicated in various biological processes, including aging and cellular regulation. Its biological activity makes it a valuable tool for research in the fields of metabolism, epigenetics, and age-related diseases.

    5 mg
    $40.00
    10 mg
    $65.00
    All 5 sizes
  • WAY-354574
    Cat. No.
    A56993

    WAY-354574

    WAY-354574 is a potent ligand for sirtuin deacetylases, primarily utilized in research related to Huntington's disease (HD). This compound modulates sirtuin activity, impacting cellular processes associated with neurodegeneration. Researchers can apply WAY-354574 to investigate the therapeutic potential and molecular mechanisms underlying HD and related disorders.

    5 mg
    $35.00
    10 mg
    $55.00
    All 4 sizes
  • CHIC35
    Cat. No.
    A56994

    CHIC35

    CHIC35 is a selective inhibitor of SIRT1, exhibiting an IC50 of 0.124 μM. It demonstrates preferential inhibition of SIRT1 over SIRT2 (IC50=2.8 μM) and SIRT3 (IC50>100 μM). This compound is recognized for its anti-inflammatory properties and is applicable in research related to CHARGE syndrome.

    25 mg
    $1,405.00
    50 mg
    $1,790.00
    All 3 sizes
  • CL5D
    Cat. No.
    A56995

    CL5D

    CL5D is a selective activator of the protein deacetylase SIRT6, enhancing its deacetylation activity and catalytic efficiency. By promoting conformational changes, specifically involving the Arg-65 residue, CL5D serves as a valuable tool for investigating the regulatory mechanisms of SIRT6. This compound is applicable in research areas related to metabolism, DNA repair, and aging, facilitating a deeper understanding of SIRT6’s biological functions.

    Out of stock

    All 3 sizes
  • F0911-7667
    Cat. No.
    A56996

    F0911-7667

    F0911-7667 is a potent activator of SIRT1, promoting autophagic cell death in U87MG and T98G glioblastoma cells through the activation of the AMPK-mTOR-ULK complex. Additionally, this compound has demonstrated its ability to reduce p53 acetylation in IMR32 neuroblastoma cells, providing protective effects against cell death induced by amyloid-beta (Aβ) fragments. Its unique mechanism and biological activities make it valuable for research in cancer and neurodegenerative disease models.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • SIRT1/2/3-IN-2
    Cat. No.
    A56997

    SIRT1/2/3-IN-2

    SIRT1/2/3-IN-2 is a potent inhibitor of SIRT1, SIRT2, and SIRT3, exhibiting inhibition rates of 27%, 72%, and 71% respectively at a concentration of 200 μM. This compound is instrumental in studying the roles of sirtuins in various biological processes, particularly their involvement in cancer biology. SIRT3, known as a potential tumor suppressor or promoter, has been linked to lymph node-positive breast cancer and oral squamous cell carcinoma, making SIRT1/2/3-IN-2 valuable for cancer research applications.

    1 mg
    $100.00
    5 mg
    $300.00
    All 4 sizes
  • Sirt2-IN-5
    Cat. No.
    A56998

    Sirt2-IN-5

    Sirt2-IN-5 is a selective inhibitor of SIRT2, a member of the sirtuin family involved in various cellular processes, including metabolism and stress response. This compound effectively reduces SIRT2 activity, thus influencing downstream signaling pathways associated with neuroprotection and cancer biology. It is useful in research applications focusing on the roles of SIRT2 in disease models and exploring therapeutic strategies targeting sirtuins.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • SIRT2-IN-10
    Cat. No.
    A56999

    SIRT2-IN-10

    SIRT2-IN-10 is a selective inhibitor of SIRT2, exhibiting an inhibitory concentration (IC50) of 1.3 μM. This compound is instrumental in studying its role in cancer pathology and neurodegenerative disorders, enabling research into potential therapeutic applications. Its ability to modulate SIRT2 activity makes it a valuable tool for investigating cellular mechanisms and disease progression.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Epigenetic factor-IN-1
    Cat. No.
    A57000

    Epigenetic factor-IN-1

    Epigenetic factor-IN-1 is a selective SIRT7 inhibitor that plays a crucial role in modulating epigenetic regulation. It demonstrates a strong binding affinity for the SIRT7 protein, making it an important tool for exploring the mechanisms of epigenetic modifications. This compound is particularly relevant for liver cancer research, providing insights into the role of SIRT7 in cancer biology and therapeutic development.

    Out of stock

    All 3 sizes
  • Tenovin-D3 hydrochloride
    Cat. No.
    A57001

    Tenovin-D3 hydrochloride

    Tenovin-D3 hydrochloride is a selective inhibitor of the sirtuin SirT2, which plays a crucial role in cellular regulation. This compound has been shown to enhance the expression of p21 (CDKN1A) independently of the p53 pathway. It is suitable for research applications focused on aging, cancer biology, and the modulation of cellular stress responses to explore the therapeutic potential of sirtuin inhibition.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Sirt2-IN-6
    Cat. No.
    A57002

    Sirt2-IN-6

    Sirt2-IN-6 is a potent and selective inhibitor of SIRT2, exhibiting an IC50 of 0.815 μM. It demonstrates significant biological activity in modulating SIRT2-related pathways and is valuable for cancer research applications. This compound facilitates the exploration of SIRT2's role in oncogenesis and therapeutic development.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • hsa62
    Cat. No.
    A57003

    hsa62

    hsa62 is a dual inhibitor targeting SIRT1 and SIRT2, demonstrating IC50 values of 1.3 μM and 5.5 μM, respectively. This compound effectively modulates the activity of sirtuins, enzymes involved in various cellular processes, including metabolism and aging. hsa62 is suitable for research investigating the role of sirtuins in cellular regulation, disease models, and therapeutic applications.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • DCHC
    Cat. No.
    A57004

    DCHC

    DCHC is a specific activator of SIRT1, enhancing its enzymatic activity without increasing SIRT1 expression levels. This compound is particularly useful in studies investigating mitochondrial damage and dysfunction, offering insights into metabolic regulation and cellular stress responses. DCHC's ability to activate SIRT1 makes it a valuable tool for exploring the roles of sirtuins in cellular health and disease.

    Out of stock

    All 3 sizes
  • SIRT5 inhibitor 6
    Cat. No.
    A57005

    SIRT5 inhibitor 6

    SIRT5 Inhibitor 6 is a selective and potent inhibitor of SIRT5 that functions through a substrate-competitive mechanism, demonstrating an IC50 value of 3.0 μM. This compound shows promise in therapeutic applications for septic acute kidney injury (AKI) in vivo, making it a valuable tool for research in kidney health and related pathologies.

    1 mg
    $235.00
    5 mg
    $590.00
    All 6 sizes
  • Guttiferone G
    Cat. No.
    A57007

    Guttiferone G

    Guttiferone G is a selective inhibitor of the human SIRT1 and SIRT2 deacetylases, exhibiting IC50 values of 9 μM and 22 μM, respectively. This compound demonstrates weak cytotoxicity in the A2780 human ovarian cancer cell line, with an IC50 of 8.0 μg/mL. Guttiferone G is derived from Garcinia macrophylla and may serve as a valuable tool in research studies exploring SIRT1 and SIRT2 modulation in cellular processes.

    5 mg
    $1,695.00
    All 1 sizes
  • SIRT5 inhibitor 5
    Cat. No.
    A57008

    SIRT5 inhibitor 5

    SIRT5 inhibitor 5 is a potent inhibitor of the SIRT5 enzyme, exhibiting an IC50 value of 0.21 µM. This compound functions as a substrate-competitive inhibitor, specifically not occupying the NAD+-binding pocket, thereby modulating SIRT5 activity. SIRT5 inhibitor 5 is valuable in research focused on elucidating the role of SIRT5 in metabolic pathways and providing insights into its potential implications in various diseases.

    1 mg
    $65.00
    5 mg
    $155.00
    All 7 sizes
  • SIRT5 inhibitor 4
    Cat. No.
    A57009

    SIRT5 inhibitor 4

    SIRT5 Inhibitor 4 is a selective inhibitor of the SIRT5 enzyme, demonstrating an IC50 value of 26.4 μM. This compound exhibits minimal activity against other SIRT subtypes, with an IC50 greater than 400 μM, underscoring its specificity. It serves as a valuable tool for investigating the biological roles of SIRT5 in metabolic regulation and related pathways. Research applications include studying SIRT5's involvement in cellular processes and potential therapeutic targets in metabolic disorders.

    1 mg
    $235.00
    5 mg
    $590.00
    All 6 sizes
  • SIRT6 activator 2
    Cat. No.
    A57010

    SIRT6 activator 2

    SIRT6 activator 2 is a specific activator of sirtuin 6, known for its anti-lipid accumulation properties. This compound effectively downregulates key transcription factors LXR and SREBP-1c, along with their downstream target genes involved in lipogenesis. SIRT6 activator 2 is valuable for research focused on lipid metabolism and associated diseases, enabling the exploration of therapeutic strategies targeting metabolic disorders.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • AGK7
    Cat. No.
    A57013

    AGK7

    Synonyms: SIRT2 Inhibitor; Inactive Control

    AGK7 is a selective inhibitor of sirtuin 2 (SIRT2), demonstrating significant neuroprotective effects in the context of Parkinson's disease. This compound has been shown to alleviate alpha-synuclein toxicity and improve inclusion morphology in cellular models. In addition, AGK7 effectively protects against dopaminergic cell death in both in vitro studies and Drosophila models, making it a valuable tool for researching neurodegenerative disorders.

    1 mg
    $50.00
    5 mg
    $100.00
    All 4 sizes
  • SIRT-IN-5
    Cat. No.
    A57014

    SIRT-IN-5

    SIRT-IN-5 is a selective inhibitor of SIRT3, demonstrating an IC50 value of 2.88 μM. This compound has been shown to promote the differentiation of multiple myeloma cells, facilitating increased expression of differentiation antigens such as CD49e, as well as enhancement of human immunoglobulin light chains λ and κ. SIRT-IN-5 is a valuable tool in research focused on the modulation of cellular differentiation processes in hematological malignancies.

    Out of stock

    All 3 sizes
  • Sirtuin-IN-1
    Cat. No.
    A57015

    Sirtuin-IN-1

    Sirtuin-IN-1 is a selective inhibitor of SIRT1 and SIRT2, with IC50 values of 6.2 μM and 4.2 μM, respectively. This compound has been shown to induce G1 phase cell cycle arrest, demonstrating its potential as an anti-cancer agent. Sirtuin-IN-1 is particularly effective against glioma, making it a valuable tool for research into cancer therapeutics and the exploration of sirtuin-related biological pathways.

    Out of stock

    All 3 sizes
  • Sirtuin modulator 4
    Cat. No.
    A57016

    Sirtuin modulator 4

    Sirtuin Modulator 4 is a selective SIRT1 inhibitor, demonstrating an EC50 value of 51-100 μM. This compound plays a critical role in modulating cellular pathways associated with lifespan extension and offers potential in researching a variety of conditions, including diabetes, obesity, neurodegenerative diseases, cardiovascular disorders, inflammation, and cancer. Its ability to inhibit SIRT1 makes it a valuable tool for studying the therapeutic implications of sirtuin regulation in metabolic and age-related diseases.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • SIRT1-IN-5
    Cat. No.
    A57017

    SIRT1-IN-5

    SIRT1-IN-5 is a selective modulator of the NAD-dependent protein deacetylase SIRT1. It demonstrates significant activity in regulating deacetylation processes, contributing to cellular metabolism and stress response. This compound can be utilized in research focused on aging, metabolic diseases, and neurodegenerative disorders, making it a valuable tool for exploring the therapeutic potential of SIRT1 modulation.

    1 mg
    $155.00
    5 mg
    $395.00
    All 6 sizes

Items 101-125 of 151

Added to your cart

View Cart Checkout

    Loading...